Naarden Jacob Van's Net Worth

$29.8 Million

Estimate Recalculated Nov 11, 2024 07:36AM EST

Who is Naarden Jacob Van

Naarden Jacob Van has an estimated net worth of $29.8 Million. This is based on reported shares across multiple companies, which include ELI LILLY & Co, and Loxo Oncology, Inc..

SEC CIK

Naarden Jacob Van's CIK is 0001661254

Past Insider Trading and Trends

2018 was Naarden Jacob Van's most active year for acquiring shares with 29 total transactions. Naarden Jacob Van's most active month to acquire stocks was the month of January. 2018 was Naarden Jacob Van's most active year for disposing of shares, totalling 137 transactions. Naarden Jacob Van's most active month to dispose stocks was the month of October. 2024 saw Naarden Jacob Van paying a total of $1,746,568.94 for 9,010 shares, this is the most they've acquired in one year. In 2019 Naarden Jacob Van cashed out on 541,969 shares for a total of $127,362,715.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ELI LILLY & Co

EVP & Pres., Lilly Oncology
Updated Nov 01, 2024
Form 4
-26.64%
-4.30K
Nov 01, 2024
20.49K
Grant
Oct 31
Form 4
39.13%
5.39K
$737.26
$1.75M
Feb 14, 2024
23.51K
Grant
Feb 12
Form 4
-10.90%
-1.69K
$645.61
-$1.09M
Feb 02, 2024
18.12K
Options
Feb 01
Form 4
-9.99%
-1.31K
$335.01
-$440.20K
Feb 21, 2023
16.19K
Options
Feb 16
Form 4
30.21%
2.41K
$345.12
$830.70K
Feb 14, 2023
14.72K
Grant
Feb 10
Form 4
-21.53%
-2.19K
$243.84
-$533.03K
Feb 17, 2022
12.31K
Options
Feb 16
Form 4
3.62K
Dec 30, 2021
3.62K
Grant
Dec 28
Form 3
Sep 07, 2021
9.03K
Showing 8 results

Loxo Oncology, Inc.

Chief Operating Officer
Updated Feb 15, 2019
Form 4
-100.00%
-541.97K
$235.00
-$127.36M
Feb 15, 2019
Disposition
Feb 15
Form 4/A
12.84%
1.54K
$3.65
$5.62K
Jan 17, 2019
13.54K
Options
ScheduledJul 09
Form 4
57.00K
Jan 02, 2019
57.00K
Grant
Jan 02
Form 4
-6.34%
-9.00K
$72.40
-$1.07M
Dec 12, 2018
132.97K
Sale
ScheduledDec 10 - Dec 11
Form 4
-6.58%
-10.00K
$76.84
-$1.42M
Nov 28, 2018
141.97K
Sale
ScheduledNov 26 - Nov 27
Form 4
-13.89%
-10.00K
$84.39
-$1.61M
Oct 05, 2018
61.97K
Sale
ScheduledOct 04 - Oct 04
Form 4
-12.20%
-10.00K
$84.99
-$1.63M
Sep 14, 2018
71.97K
Sale
ScheduledSep 12 - Sep 13
Form 4
-10.87%
-10.00K
$81.50
-$1.56M
Aug 15, 2018
81.97K
Sale
ScheduledAug 13 - Aug 14
Form 4
-3.24%
-3.08K
$93.58
-$554.30K
Jul 11, 2018
91.97K
Sale
ScheduledJul 09 - Jul 10
Form 4
-3.14%
-3.08K
$90.90
-$494.02K
Jun 21, 2018
95.05K
Sale
ScheduledJun 19 - Jun 20
Form 4
-3.05%
-3.08K
$70.54
-$412.27K
May 16, 2018
98.13K
Sale
ScheduledMay 14 - May 15
Form 4
-2.96%
-3.08K
$67.44
-$393.22K
Apr 26, 2018
101.22K
Sale
ScheduledApr 24 - Apr 25
Form 4
-2.87%
-3.08K
$67.53
-$393.75K
Mar 15, 2018
104.30K
Sale
ScheduledMar 13 - Mar 14
Form 4
-2.79%
-3.08K
$50.00
-$285.67K
Feb 14, 2018
107.38K
Sale
ScheduledFeb 12 - Feb 13
Form 4
-2.71%
-3.08K
$45.93
-$260.62K
Jan 18, 2018
110.46K
Sale
ScheduledJan 16 - Jan 17
Form 4
200.00K
Jan 05, 2018
200.00K
Grant
Jan 04
Form 4
-2.64%
-3.08K
$42.42
-$239.00K
Dec 18, 2017
113.54K
Sale
ScheduledDec 14 - Dec 15
Form 4
-2.57%
-3.08K
$39.08
-$218.35K
Nov 29, 2017
116.63K
Sale
ScheduledNov 27 - Nov 28
Form 4
-2.51%
-3.08K
$45.27
-$256.55K
Nov 01, 2017
119.71K
Sale
ScheduledOct 30 - Oct 31
Form 4
-2.45%
-3.08K
$46.33
-$263.05K
Sep 20, 2017
122.79K
Sale
ScheduledSep 18 - Sep 19
Form 4
-2.39%
-3.08K
$38.61
-$215.51K
Aug 16, 2017
125.87K
Sale
ScheduledAug 14 - Aug 15
Form 4
35.00K
Mar 17, 2017
35.00K
Grant
Mar 15
Form 4
74.00K
Dec 08, 2016
74.00K
Grant
Dec 06
Form 3
Mar 08, 2016
Showing 24 results